Levocetirizine, Montelukast and ambroxol are three medications commonly prescribed for respiratory conditions and allergies Levocetirizine a second generation antihistamine alleviates allergic symptoms by blocking histamine receptors in the body, effectively reducing symptoms like sneezing itching and a runny nose associated with allergic rhinitis and urticaria.
Montelukast classified as a leukotriene receptor antagonist targets inflammatory mediators involved in asthma and allergic rhinitis by blocking leukotriene action Montelukast helps prevent and manage asthma and provides relief from symptoms like wheezing and shortness of breath. Administered orally once daily, montelukast is generally safe although some individuals may experience Headache or gastrointestinal discomfort.
Ambroxol a mucolytic agent, acts by thinning and loosening mucus in the respiratory tract, making it easier to clear from the airways. Widely used in conditions characterized by excessive mucus production such as bronchitis and pneumonia, ambroxol facilitates coughing and promotes mucus clearance thereby improving respiratory function.